Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

Report of Foreign Private Issuer
Pursuant to Rules 13a-16 or 15d-16 under
the Securities Exchange Act of 1934

 

For the month of October 2024

 

Commission File Number: 001-38836

 

BIOCERES CROP SOLUTIONS CORP.

(Translation of registrant’s name into English)

 

Ocampo 210 bis, Predio CCT, Rosario

Province of Santa Fe, Argentina

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F x                               Form 40-F  ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

 

 

 

 

 

 

Exhibit List

 

Exhibit No.		Description
99.1		1. Notice and Proxy Materials for the 2024 Annual General Meeting of Bioceres Crop Solutions Corp.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	BIOCERES CROP SOLUTIONS CORP.
	(Registrant)
Dated: October 3, 2024	By:	/s/ Federico Trucco
	Name:	Federico Trucco
	Title:	Chief Executive Officer

 

 

 

 

Exhibit 99.1

 

 

 

www.biocerescrops.com

 

Ocampo 210 bis

Predio CCT Rosario

(2000) Rosario, Santa Fe, Argentina

 

T: [phone]

E: [e-mail]

 

October 3, 2024

 

Dear Shareholder,

 

You are cordially invited to attend the 2024 Annual General Meeting (the “Annual General Meeting”) of Bioceres Crop Solutions Corp. (the “Company”) to be held at 10:00 a.m. EDT on October 24, 2024 at the Company’s legal counsel’s office, 1290 Avenue of the Americas, New York, NY 10104, and virtually according to the details below. Information concerning the matters to be considered and voted upon at the Annual General Meeting is set out in the attached Convening Notice and Proxy Statement.

 

The Board of Directors has fixed September 30, 2024 (5:00 p.m. Buenos Aires time, 4:00 p.m. EDT) as the record date for the Annual General Meeting (the “Record Date”), and only holders of record of shares at such time will be entitled to notice of or to vote at the Annual General Meeting or any adjournment thereof.

 

If you are unable to attend the Annual General Meeting in person or virtually or you wish to be represented, please authorize a proxy to vote your shares in accordance with the instructions you received. This will not prevent you from voting your shares in person or virtually if you subsequently choose to attend our Annual General Meeting.

 

Please note that powers of attorney or proxy cards must be received by the tabulation agent (Continental Stock), no later than 11:59 p.m. EDT, on October 23, 2024 for such votes to be taken into account.

 

On behalf of the Board of Directors, we thank you for your continued support.

 

	Sincerely,
	Federico Trucco
	Chief Executive Officer

 

 

 

 

 

 

www.biocerescrops.com

 

Ocampo 210 bis

Predio CCT Rosario

(2000) Rosario, Santa Fe, Argentina

 

T: [phone]

E: [e-mail]

 

Convening Notice to

the 2024 Annual General Meeting

to be held on October 24, 2024 at 10:00 a.m. EDT at 1290 Avenue of the Americas, New York, NY 10104

 

October 3, 2024

 

Dear Shareholder,

 

The Board of Directors of Bioceres Crop Solutions Corp. (the “Company”) is pleased to invite you to attend the 2024 Annual General Meeting (the “Annual General Meeting”), to be held on October 24, 2024 at 10:00 a.m. EDT at 1290 Avenue of the Americas, New York, NY 10104 and virtually according to the details below, with the following agenda:

 

Agenda of the 2024 Annual General Meeting

 

1.

Consider the report of the Board of Directors of the Company and the report of the independent auditors of the Company’s consolidated financial statements for the financial year ended June 30, 2024 and to approve the Company’s consolidated financial statements for the financial year ended June 30, 2024.

 

2.

Consider and vote upon a proposal to appoint the following six directors to serve on the board of directors of the Company until the 2025 annual general meeting of the Company or until their respective successors are duly appointed and qualified:

 

i.

Federico Trucco

ii.

Gloria Montaron Estrada

iii.

Enrique Lopez Lecube

iv.

Natalia Zang

v.

Keith McGovern

vi.

Yogesh Mago

 

3.

Consider and vote upon the ratification of appointment of Price Waterhouse & Co. S.R.L. as the independent registered public accounting firm of the Company.

 

The holders of a majority of the ordinary shares being individuals present in person (which shall include virtual presence using one of the options provided) or by proxy or if a corporation or other non-natural person by its duly authorized representative or proxy shall be a quorum for all purposes, including adopting the resolutions at the Annual General Meeting.

 

 

 

 

Any shareholder who holds one or more ordinary share(s) of the Company on September 30, 2024 at 5:00 p.m. Buenos Aires time, 4:00 p.m. EDT (the “Record Date”) will be admitted to the Annual General Meeting and may attend the Annual General Meeting, as applicable, in person (which shall include virtual presence using one of the options provided) or vote by proxy.

 

Please consult the Proxy Statement enclosed herewith and available on the Company’s website as to the procedures for attending the Annual General Meeting or to be represented by way of proxy. Copies of the Company’s consolidated financial statements for the financial year ended June 30, 2024 together with the reports of the Board of Directors will be available at https://investors.biocerescrops.com/home/default.aspx. Please note that powers of attorney or proxy cards must be received by the tabulation agent (Continental Stock), no later than 11:59 p.m. EDT, on October 23, 2024 in order for such votes to be taken into account.

 

Sincerely,
Federico Trucco
Chief Executive Officer on behalf of the Board of Directors

 

 

 

 

BIOCERES CROP SOLUTIONS CORP.

 

PROXY STATEMENT

ANNUAL GENERAL MEETING

OCTOBER 24, 2024

 

GENERAL INFORMATION

 

This Proxy Statement is being provided to solicit proxies on behalf of the Board of Directors of Bioceres Crop Solutions Corp. (the “Company,” or “we”) for use at the 2024 Annual General Meeting (the “Annual General Meeting”) to be held on October 24, 2024, at 10:00 a.m. EDT at the Company’s legal counsel’s office, 1290 Avenue of the Americas, New York, NY 10104, and any adjournment thereof. This Proxy Statement is available on our website at https://investors.biocerescrops.com/home/default.aspx which will also post the Company’s consolidated financial statements for the financial year ended June 30, 2024 together with the report of the Board of Directors.

 

This Proxy Statement, together with the Convening Notice containing the agenda and the proxy card with reply envelope, are hereinafter referred to as the “Proxy Materials”.

 

Foreign Private Issuer

 

We are a “foreign private issuer” within the meaning of Rule 3b-4 of the U.S. Securities Exchange Act of 1934, as amended, and as a result, we are not required to mandatorily comply with U.S. federal proxy requirements.

 

Simultaneous Virtual and Telephone Access

 

You will be able, and we encourage you, to attend the Annual General Meeting by telephone or virtually by webex.

 

You will be able to connect:

 

	(i)	Telephone access (listen-only):
		Within the U.S. and Canada: 1 800-450-7155 (toll-free)
		Outside of the U.S. and Canada: [phone] (standard rates apply)
		Passcode for telephone access:
		7365383#

 

	(ii)	by webex (video system or application)
		https://www.cstproxy.com/biocerescrops/2024
		Control Number: will be supplied on the proxy card or you can contact Continental to join the meeting. You will be able to vote through the virtual meeting.

 

 

 

 

Record Date, Share Ownership and Quorum

 

Only holders of record of the Company’s ordinary shares, par value US$0.0001 per share, at 5:00 p.m. Buenos Aires time, 4:00 p.m. EDT on September 30, 2024 (the “Record Date”) are entitled to attend and vote at the Annual General Meeting in respect of such ordinary shares. The holders of a majority of the ordinary shares issued and outstanding being individuals present in person (which shall include virtual presence using one of the options provided) or by proxy or if a corporation or other non-natural person by its duly authorized representative or proxy shall be a quorum for all purposes.

 

Voting and Solicitation

 

Each ordinary share issued and outstanding as of the Record Date is entitled to one vote at the Annual General Meeting. Each of the resolutions at the Annual General Meeting will be adopted by an ordinary resolution under Cayman Islands law which is a resolution passed by a simple majority of the shareholders who vote at the Annual General Meeting, either in person (which shall include virtual presence using one of the options provided) or by proxy.

 

Copies of solicitation materials will be furnished to all holders of ordinary shares of the Company, including banks, brokerage houses, fiduciaries and custodians holding in their names ordinary shares of the Company beneficially owned by others to forward to those beneficial owners.

 

Voting by Holders of Ordinary Shares

 

When proxy forms are properly dated, executed and returned by holders of ordinary shares to the mailing or e-mail address set forth in the proxy form before 11:59 p.m. EDT, on October 23, 2024 (the deadline for the return of such proxy forms), the ordinary shares they represent will be voted by the proxy holder at the Annual General Meeting, or at any adjournment thereof, in accordance with the instructions of the shareholder. If no specific instructions are given in such proxy forms, the proxy holder will vote in favor of the items set forth in the proxy form. The proxy holder will also vote in the discretion of such proxy holder on any other matters that may properly come before the Annual General Meeting, or at any adjournment thereof. Where any holder of ordinary shares affirmatively abstains from voting on any particular resolution, the votes attaching to such ordinary shares will not be included or counted in the determination of the number of ordinary shares present and voting for the purposes of determining whether such resolution has been passed (but they will be counted for the purposes of determining the quorum, as described above).

 

Revocability of Proxies

 

Any proxy given by a holder of ordinary shares by means of a proxy form pursuant to this solicitation may be revoked: (a) by submitting a written notice of revocation or a fresh proxy form, bearing a later date, which must be received by Continental Stock, no later than 11:59 p.m. EDT, on October 23, 2024 or (b) by attending the Annual General Meeting and voting in person (which shall include virtual presence using one of the options provided).

 

 

 

 

PROPOSAL WITH RESPECT TO AGENDA ITEM NO. 1:

APPROVAL OF CONSOLIDATED FINANCIAL STATEMENTS

 

At the Annual General Meeting, the Board of Directors will present the management report on the Company’s consolidated financial statements, as well as the report of the independent auditor of the Company’s consolidated financial statements for the financial year ended June 30, 2024. The management report and the independent auditor’s report are available on the internet at https://investors.biocerescrops.com/home/default.aspx. Following such presentation, the following resolutions will be put before the Annual General Meeting for approval:

 

“Resolved, as an ordinary resolution, that after having reviewed the report of the Board of Directors of the Company and the report of the independent auditor on the Company’s consolidated financial statements for the financial year ended June 30, 2024, the consolidated financial statements of the Company for the financial year ended June 30, 2024 be approved in all respects in their entirety.”

 

Our Board of Directors recommends a vote “FOR” the approval of the Company’s consolidated financial statements for the financial year ended June 30, 2024.

 

PROPOSAL WITH RESPECT TO AGENDA ITEM NO. 2:

 

At the Annual General Meeting, the shareholders will be asked to appoint six directors to the Board of Directors of the Company to serve until the 2025 annual general meeting of the Company or until or until their respective successors are duly appointed and qualified.

 

The Board of Directors has nominated Federico Trucco; Gloria Montaron Estrada; Enrique Lopez Lecube; Natalia Zang; Keith McGovern and Yogesh Mago to serve as directors of the Company until the 2025 annual general meeting of the Company or until their respective successors are duly appointed and qualified.

 

“Resolved, as an ordinary resolution, that the following persons be appointed as directors of the Company, each to hold office until the 2025 annual general meeting of the Company or until their respective successors are duly appointed and qualified: (i) Federico Trucco; (ii) Gloria Montaron Estrada; (iii) Enrique Lopez Lecube; (iv) Natalia Zang; (v) Keith McGovern and (vi) Yogesh Mago.”

 

Our Board of Directors recommends a vote “FOR” the election of each of the six director nominees to the Board of Directors.

 

PROPOSAL WITH RESPECT TO AGENDA ITEM NO. 3:

RATIFICATION OF APPOINTMENT OF PRICE WATERHOUSE & CO. S.R.L. AS

THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY

 

At the Annual General Meeting, the shareholders will be asked to approve the following resolution:

 

“Resolved, as an ordinary resolution, that the appointment of Price Waterhouse & Co. S.R.L. as the independent registered public accounting firm of the Company for the period ending at the 2025 annual general meeting be approved in all respects.”

 

Our Board of Directors recommends a vote “FOR” the appointment of Price Waterhouse & Co. S.R.L. as the independent registered public accounting firm of the Company for the period ending at the 2025 annual general meeting.

 

 

 

 

SHAREHOLDER COMMUNICATIONS

 

Shareholders and interested parties may contact any of the Company’s directors, the chair of any committee of the Board of Directors or any committee of the Board by writing them as follows:

 

Bioceres Crop Solutions Corp.

Ocampo 210 bis

Predio CCT Rosario

(2000) Rosario, Santa Fe, Argentina

Attn: Company Secretary

 

Concerns relating to accounting, internal controls or auditing matters should be communicated to the Company through the Company Secretary and will be handled in accordance with the procedures established by the audit committee with respect to such matters.

 

 

 

 

WHERE YOU CAN FIND MORE INFORMATION

 

The Company files annual and special reports and other information with the SEC.

 

The Company’s SEC filings are also available to the public on the SEC’s internet website at www.sec.gov. In addition, the Company’s SEC filings are also available to the public on the Company’s website, www.biocerescrops.com. Information contained on the Company’s website is not incorporated by reference into this document, and you should not consider information contained on that website as part of this document.

 

Important Notice Regarding the Availability of Proxy Materials for the
Annual General Meeting to be held on October 24, 2024

 

Information is now available regarding the 2024 Annual General Meeting (the “Annual General Meeting”) at https://investors.biocerescrops.com/home/default.aspx.

 

YOUR VOTE IS IMPORTANT. OUR BOARD OF DIRECTORS URGES YOU TO VOTE BY
MARKING, DATING, SIGNING AND RETURNING A PROXY CARD.

 

With respect to all of the proposals and matters considered at the Annual General Meeting, shares held through a broker or other intermediary will not be voted unless the beneficial holder notifies the broker or other intermediary through which the shares are held with instructions regarding how to vote. We strongly encourage you to provide instructions to your broker or other intermediary to vote your shares and exercise your right as a shareholder.

 

If you wish to attend the Annual General Meeting in person (which shall include virtual presence using one of the options provided), you must reserve your seat by October 20, 2024 by contacting José Augusto Roque at [e-mail]. However, we encourage you using other methods of attendance than in person (which shall include virtual presence using one of the options provided), such as attending virtually or telephonically or by proxy. Please note that there may be certain restrictions to access the premises in person.

 

If you are a holder of record of our ordinary shares as at the Record Date, you will be admitted to the meeting upon presenting a form of photo identification. If you own ordinary shares beneficially through a bank, broker or otherwise, you will be admitted to the Annual General Meeting upon presenting a form of photo identification and proof of share ownership as at the Record Date; in order to vote at the Annual General Meeting you must bring a valid proxy signed by the record holder. A recent brokerage statement reflecting your ownership as at 5:00 p.m. Buenos Aires time, 4:00 p.m. EDT on September 30, 2024 (the “Record Date”) or a letter from a bank or broker confirming your ownership as at the Record Date are examples of proof of share ownership for purposes of admission to the Annual General Meeting. If you are a holder of ordinary shares you will be entitled to vote at the Annual General Meeting or any adjournment thereof.

 

Regardless of whether or not you plan to attend the Annual General Meeting, please follow the instructions you received to authorize a proxy to vote your shares as soon as possible to ensure that your shares are represented at the Annual General Meeting. Any shareholder that decides to attend the Annual General Meeting in person (which shall include virtual presence using one of the options provided) may, if so desired, revoke the prior proxy by voting such person’s ordinary shares at the Annual General Meeting as further described in the Proxy Statement under the heading “Revocability of Proxies”.

 

Argentina

October 3, 2024

 

 

 

---